1. Home
  2. SHMD vs GBIO Comparison

SHMD vs GBIO Comparison

Compare SHMD & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHMD
  • GBIO
  • Stock Information
  • Founded
  • SHMD 1864
  • GBIO 2016
  • Country
  • SHMD Germany
  • GBIO United States
  • Employees
  • SHMD N/A
  • GBIO N/A
  • Industry
  • SHMD
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHMD
  • GBIO Health Care
  • Exchange
  • SHMD Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • SHMD 102.1M
  • GBIO 29.5M
  • IPO Year
  • SHMD N/A
  • GBIO 2020
  • Fundamental
  • Price
  • SHMD $2.22
  • GBIO $5.77
  • Analyst Decision
  • SHMD
  • GBIO Buy
  • Analyst Count
  • SHMD 0
  • GBIO 4
  • Target Price
  • SHMD N/A
  • GBIO $10.67
  • AVG Volume (30 Days)
  • SHMD 30.8K
  • GBIO 76.7K
  • Earning Date
  • SHMD 01-01-0001
  • GBIO 11-05-2025
  • Dividend Yield
  • SHMD N/A
  • GBIO N/A
  • EPS Growth
  • SHMD N/A
  • GBIO N/A
  • EPS
  • SHMD N/A
  • GBIO N/A
  • Revenue
  • SHMD $85,165,542.00
  • GBIO $21,230,000.00
  • Revenue This Year
  • SHMD N/A
  • GBIO N/A
  • Revenue Next Year
  • SHMD N/A
  • GBIO N/A
  • P/E Ratio
  • SHMD N/A
  • GBIO N/A
  • Revenue Growth
  • SHMD N/A
  • GBIO 61.15
  • 52 Week Low
  • SHMD $1.86
  • GBIO $3.00
  • 52 Week High
  • SHMD $4.40
  • GBIO $29.10
  • Technical
  • Relative Strength Index (RSI)
  • SHMD 37.92
  • GBIO 50.66
  • Support Level
  • SHMD $2.00
  • GBIO $5.51
  • Resistance Level
  • SHMD $2.48
  • GBIO $6.04
  • Average True Range (ATR)
  • SHMD 0.21
  • GBIO 0.32
  • MACD
  • SHMD -0.02
  • GBIO -0.10
  • Stochastic Oscillator
  • SHMD 30.07
  • GBIO 26.80

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: